NCT04961385View on ClinicalTrials.gov

Immunogenicity of the ChAdox1 n CoV-19 Vaccine With 12-dose Vial

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

May 31, 2021

Study Completion Date

May 31, 2021

Conditions
Covid19VaccineImmunogenicity
Interventions
BIOLOGICAL

Immunogenicity after first dose of participants who received first dose of ChAdox-1 n COV-19 vaccine

Blood samples were taken from the vaccinated participants for antibody testing against SARS-CoV-2

Trial Locations (1)

10300

Thananda Trakarnvanich, Bangkok

All Listed Sponsors
lead

Bangkok Metropolitan Administration Medical College and Vajira Hospital

OTHER_GOV

NCT04961385 - Immunogenicity of the ChAdox1 n CoV-19 Vaccine With 12-dose Vial | Biotech Hunter | Biotech Hunter